Federal contract award

75N92024P00266

WHOLE GENOME DNA METHYLATION AND GENOTYPING FOR SLE PATIENTS, THIRD PHASE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NHLBI
NAICS611310 — Colleges, Universities, and Professional Schools
PSCQ301 — Reference Laboratory Testing
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$282.8K
Current contract value$282.8K
Potential contract value / ceiling$282.8K
Start dateSep 8, 2024
Current end dateApr 30, 2026
Potential end dateApr 30, 2026
Latest award activityAug 18, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 18, 2025P00001$0WHOLE GENOME DNA METHYLATION AND GENOTYPING FOR SLE PATIENTS, THIRD PHASE
Sep 5, 20240$282.8KWHOLE GENOME DNA METHYLATION AND GENOTYPING FOR SLE PATIENTS, THIRD PHASE

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Maxwell, Dorothy L.Contactdorothy.maxwell@nih.gov
301-827-7729
SourceJul 31, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.